● Recruiting

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

Condition: Atopic Dermatitis · Sleep Disturbance · Sponsor: Northwestern University

PhasePhase 4

Planned participants40

Who can joinAll sexes, 6 Years to 17 Years

Healthy volunteersNo

About this study

Single center, prospective, Open label study of sleep, pruritus and circadian function pre/post 12-weeks of dupilumab treatment in children 6-17 years old

This description comes directly from the study's public registry record.

Talk to the study team

Dermatology CTU · 312-227-6817 · eczemasleepstudy@northwestern.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Lurie Children's Hospital/Northwestern University

Chicago, Illinois, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05042258